[
  {
    "ts": "2026-01-14T13:05:00+00:00",
    "headline": "Integrated DNA Technologies Expands Synthetic Biology Portfolio with Ansa Biotechnologies’ Clonal DNA and XL Clonal DNA Products",
    "summary": "SUNNYVALE, Calif. & EMERYVILLE, Calif., January 14, 2026--IDT and Ansa are joining forces to empower customers with sequence-perfect constructs up to 50 kb, expanding IDT's synthetic biology portfolio.",
    "url": "https://finance.yahoo.com/news/integrated-dna-technologies-expands-synthetic-130500202.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "2935d9ff-5fbc-355e-8c79-ae478a40f5b2",
      "content": {
        "id": "2935d9ff-5fbc-355e-8c79-ae478a40f5b2",
        "contentType": "STORY",
        "title": "Integrated DNA Technologies Expands Synthetic Biology Portfolio with Ansa Biotechnologies’ Clonal DNA and XL Clonal DNA Products",
        "description": "",
        "summary": "SUNNYVALE, Calif. & EMERYVILLE, Calif., January 14, 2026--IDT and Ansa are joining forces to empower customers with sequence-perfect constructs up to 50 kb, expanding IDT's synthetic biology portfolio.",
        "pubDate": "2026-01-14T13:05:00Z",
        "displayTime": "2026-01-14T13:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/8ee13e29e254530be51252244afe0830",
          "originalWidth": 480,
          "originalHeight": 270,
          "caption": "Integrated DNA Technologies and Ansa Biotechnologies announced a new collaboration to enable researchers to design and assemble longer, more complex constructs, delivering a new standard for speed, precision and reliability in synthetic biology.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/11VTuPjN8VI2kXoWF.v9Zw--~B/aD0yNzA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/8ee13e29e254530be51252244afe0830.cf.webp",
              "width": 480,
              "height": 270,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OkMAo330gICO42z4IeGPTg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/8ee13e29e254530be51252244afe0830.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/integrated-dna-technologies-expands-synthetic-130500202.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/integrated-dna-technologies-expands-synthetic-130500202.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DHR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-14T12:57:19+00:00",
    "headline": "Danaher (DHR) Rebounded on Accelerated Demand",
    "summary": "Mar Vista Investment Partners, LLC, an investment management company, released its “Mar Vista U.S. Quality Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. US equities experienced a strong momentum in 2025 and marked their second consecutive year of double-digit gains. The market witnessed one of the fastest recoveries following its […]",
    "url": "https://finance.yahoo.com/news/danaher-dhr-rebounded-accelerated-demand-125719176.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "d5cb08fe-5d50-3ae4-916e-163336bf5b03",
      "content": {
        "id": "d5cb08fe-5d50-3ae4-916e-163336bf5b03",
        "contentType": "STORY",
        "title": "Danaher (DHR) Rebounded on Accelerated Demand",
        "description": "",
        "summary": "Mar Vista Investment Partners, LLC, an investment management company, released its “Mar Vista U.S. Quality Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. US equities experienced a strong momentum in 2025 and marked their second consecutive year of double-digit gains. The market witnessed one of the fastest recoveries following its […]",
        "pubDate": "2026-01-14T12:57:19Z",
        "displayTime": "2026-01-14T12:57:19Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/4de858d44070a1d168359ecccfcc604b",
          "originalWidth": 768,
          "originalHeight": 430,
          "caption": "Danaher Corporation (DHR) Is \"Fool's Gold,\" Bemoans Jim Cramer",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GUGl..cccct8B.5GAQgZ9Q--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4de858d44070a1d168359ecccfcc604b.cf.webp",
              "width": 768,
              "height": 430,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jx.zT_h64bQMq1zS__HQvw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4de858d44070a1d168359ecccfcc604b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/danaher-dhr-rebounded-accelerated-demand-125719176.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/danaher-dhr-rebounded-accelerated-demand-125719176.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DHR"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-14T18:44:28+00:00",
    "headline": "JPM26: Danaher positioned to improve patient diagnostics",
    "summary": "Danaher anticipates a strong 2026 due to its diagnostic portfolio being in highly attractive areas such as molecular testing, pathology and blood gas, and in core lab.",
    "url": "https://www.medicaldevice-network.com/analyst-comment/jpm26-danaher-positioned-to-improve-patient-diagnostics/",
    "source": "Medical Device Network",
    "provider": "yfinance",
    "raw": {
      "id": "1b702419-47db-3b25-a83d-7cdbdb6d8116",
      "content": {
        "id": "1b702419-47db-3b25-a83d-7cdbdb6d8116",
        "contentType": "STORY",
        "title": "JPM26: Danaher positioned to improve patient diagnostics",
        "description": "",
        "summary": "Danaher anticipates a strong 2026 due to its diagnostic portfolio being in highly attractive areas such as molecular testing, pathology and blood gas, and in core lab.",
        "pubDate": "2026-01-14T18:44:28Z",
        "displayTime": "2026-01-14T18:44:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medical_device_network_744/a1ada1e6d00a3b170eaaa11481188a9c",
          "originalWidth": 1440,
          "originalHeight": 1080,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yGLKm92cv.rce9XARd6vEQ--~B/aD0xMDgwO3c9MTQ0MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/medical_device_network_744/a1ada1e6d00a3b170eaaa11481188a9c.cf.webp",
              "width": 1440,
              "height": 1080,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IvojKndjQpNrCRxVb5yFMw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medical_device_network_744/a1ada1e6d00a3b170eaaa11481188a9c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Medical Device Network",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medicaldevice-network.com/analyst-comment/jpm26-danaher-positioned-to-improve-patient-diagnostics/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpm26-danaher-positioned-improve-patient-184428331.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DHR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]